Response of Regenerative Therapy in Non-Hair Treatment Patients with Androgenetic Alopecia Approved for Hairmetrix Technology - Case Report

    Filipe Kawakami Duarte Da Silva
    Image of study
    TLDR Rigenera® effectively improves hair condition in Androgenetic Alopecia, and HairMetrix® tracks progress well.
    This study evaluated the effectiveness of using autologous cells prepared with the Rigenera® system in treating Androgenetic Alopecia in 8 male patients aged 33 to 44. Over 7 months, HairMetrix® technology was used to monitor changes in miniaturized hairs, hair density, and hair length. The results showed significant improvement in hair condition, with all patients expressing satisfaction. The study concludes that Rigenera® is a powerful, minimally invasive technology for hair recovery, and HairMetrix® effectively tracks treatment progress.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 16 results

    Similar Research

    5 / 1000+ results